Board Member
Enliven Therapeutics, Inc. (ELVN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Rick Fair is recorded as Board Member and CEO at Enliven Therapeutics, Inc. (ELVN). Enliven Therapeutics, Inc. reported in an 8-K filed December 11, 2025 that Rick Fair was appointed member of the Board of Directors, effective December 11, 2025. Enliven Therapeutics, Inc. reported in an 8-K filed December 11, 2025 that Rick Fair was appointed Chief Executive Officer, effective December 11, 2025. Rick Fair has spoken on 1 investor event across 1 company, most recently for Enliven Therapeutics, Inc. on June 4, 2026.
“Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced the appointment of Rick Fair as Chief Executive Officer and member of the Board of Directors of Enliven, effective December 11, 2025.”
“Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced the appointment of Rick Fair as Chief Executive Officer and member of the Board of Directors of Enliven, effective December 11, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2025-12-11–present
2025-12-11–present
Recorded roles and call appearances connecting this person to public companies.
Board Member, CEO
2025-12-11–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
